Statistically when applying for SSDI benefits chances are you will be denied. A denial leaves you with three choices: Accept the denial and forget it. Appeal the denial. Make a fresh application. The first consideration is why you were denied. If it was for a technical reason, like you are still working and making too… Read more

The leading cause of accidental death is motor vehicle crashes. The next leading cause of accidental deaths is poisoning, particularly from overdoses of over-the-counter, prescription, and illicit drugs. Death by poisoning is the fastest rising cause of accidental death. Researchers at the Northwestern University’s Feinberg School of Medicine recently did a study involving 119 patients… Read more

Chronic pain often leads to significant changes in a person’s daily routine. It is difficult to bend or stand for long periods of time because of the pain. Sleep is difficult and even taking a bath or shower can become a challenge. Pain medications are often the first form of treatment, but often the side effects make… Read more

International Association for the Study of Pain, reports in its publication, Pain: Clinical Updates, that despite Ketamine being used in large doses for the past 4 decades as a general anesthesia little is known about its effectiveness for pain management in low dosages. There is evidence that low dosages of Ketamine is useful for pathological… Read more

University of Missouri Columbia, reports that with the National Institutes of Health $6 million grant, and matching funds from the university, they are beginning phase 2 of their Alzheimer’s disease study. The disease affects 15 to 20 million people worldwide today and is expected to triple by 2050 when 24% of the population will be… Read more

Pharmaceutical company, Novartis, produces Exelon that is used in the treatment of Alzheimer’s disease. A recent Exelon promotional brochure distributed to health-care professionals has caught the eye of the FDA because it is thought to be misleading. The FDA faxed a warning to Novartis that states that Exelon is associated with numerous risks and that Novartis… Read more

Business Week, June 13, Kerry Capell reports that conservatives agree with Michael Moore’s recent film that blasts the U.S. health-care system. In his film, Sicko, Moore’s premise is that the U.S. health care system is worse than any other modern country. His premise is supported by a Commonwealth Fund study that compares the U.S. health-care… Read more

NYU Medical Center researchers’ recent study focused on energy metabolism in the brain because little work has been done in this area and recent studies indicate that this may be a good clinical indicator for those who are susceptible to Alzheimer’s. In the past 2 decades brain energy metabolism studies have shown that Alzheimer’s disease… Read more

In the first analysis of its kind to study military service personnel returning from Iraq and Afghanistan, the RAND Corporation has found: Nearly 20% of returning Iraq and Afghanistan soldiers (300K) report PTSD or major depression. Many service members failed to report PTSD or major depression fearing it would damage their career. Service members fail to… Read more

Parkinson’s disease signature symptoms are tremors, rigidity, and impaired movement associated with the progressive loss of motor skills. Currently, L-DOPA is the only relief of the common symptoms experienced by Parkinson’s disease patients, but it can cause prominent side effects that counteract its effectiveness. Paul Greengard, Rockefeller University, and colleagues in Sweden, have found evidence… Read more

Recent studies suggest that high levels of DHA (omega-3 fatty acids) indicate that it may help in warding off Alzheimer’s disease. Those with high levels of DHA were about half as likely to develop dementia as those who had lower levels. The prestigious Wake Forest University Baptist Medical Center plans to conduct a nationwide study where… Read more

A team of researchers at the University of Rochester are exploring the role inflammation plays in Alzheimer’s disease. Like Rheumatoid Arthritis, which causes inflammation and irreparable damage to joints, it appears that there is also an inflammatory mechanism involved in patients with Alzheimer’s disease that is just as destructive. The inflammation that appears in the brains… Read more